Role of glycogen synthase kinase 3 beta (GSK3β) in mediating the cytotoxic effects of the histone deacetylase inhibitor trichostatin A (TSA) in MCF-7 breast cancer cells
<p>Abstract</p> <p>Histone deacetylase inhibitors (HDACIs) have been shown to induce apoptotic and autophagic cell death <it>in vitro </it>and <it>in vivo</it>. The molecular mechanisms that underlie these cytotoxic effects are not yet clearly understood. Re...
Main Authors: | Lam Eric, Stavropoulou Alexandra V, Alao John P, Coombes R Charles |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-10-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/5/1/40 |
Similar Items
-
Histone deacetylase inhibitor, Trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells
by: Charles Coombes R, et al.
Published: (2006-02-01) -
Regulation of Autophagy by the Glycogen Synthase Kinase-3 (GSK-3) Signaling Pathway
by: Hsuan-Yeh Pan, et al.
Published: (2022-02-01) -
Glycogen synthase kinase 3 (GSK-3) and its inhibitors : drug discovery and development /
by: Martinez, Ana, 1961-, et al.
Published: (2006) -
In Silico Approaches to Developing Novel Glycogen Synthase Kinase 3β (GSK-3β)
by: Shuchi Goyal, et al.
Published: (2023-10-01) -
Glycogen synthase kinase 3 (GSK-3) controls T-cell motility and interactions with antigen presenting cells
by: Alison Taylor, et al.
Published: (2020-03-01)